UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 4, pp. 329 - 336
Life Sciences & Biomedicine | Oncology | Science & Technology | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Remission Induction | Transplantation, Homologous | Neoplasm, Residual | Young Adult | Adult | Female | Aged | Retrospective Studies | Leukemia, Myeloid, Acute - therapy | Index Medicus | ORIGINAL REPORTS | Bone1
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 10, pp. 1112 - 1121
Life Sciences & Biomedicine | Oncology | Science & Technology | Leukemia, Lymphocytic, Chronic, B-Cell - surgery | Receptors, Antigen, T-Cell - metabolism | Humans | Middle Aged | Male | Remission Induction | Transplantation Chimera | Disease Progression | T-Lymphocytes - transplantation | Transplantation, Homologous | Leukemia, B-Cell - surgery | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | T-Lymphocytes - immunology | Aged | Leukemia, B-Cell - immunology | Graft vs Host Disease - etiology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Antigens, CD19 - immunology | Index Medicus | Hema7 | Bone2 | Hema15 | To6 | Bone1 | ORIGINAL REPORTS
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 25, pp. 2691 - 2698
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Humans | Middle Aged | Male | Transplantation, Autologous | Treatment Outcome | Young Adult | Disease-Free Survival | Myelodysplastic Syndromes - therapy | Adult | Female | Aged | Myelodysplastic Syndromes - genetics | Hematopoietic Stem Cell Transplantation - methods | Mutation | Transplantation Conditioning | Index Medicus | To19 | To2 | To13 | Bone1 | To8 | ORIGINAL REPORTS | Hema9
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2014, Volume 32, Issue 29, pp. 3249 - 3256
Life Sciences & Biomedicine | Oncology | Science & Technology | Decision Making | Hematologic Neoplasms - therapy | Prognosis | Age Factors | Comorbidity | Health Status Indicators | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Transplantation, Homologous | Adult | Female | Aged | Retrospective Studies | Index Medicus | Bone2 | Bone1 | Psc12 | ORIGINAL REPORTS | Bone5
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 16, pp. 2230 - 2239
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Graft vs Host Disease - epidemiology | Age Factors | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Child, Preschool | Hematologic Diseases - surgery | Infant | Male | Hematopoietic Stem Cell Transplantation - mortality | Cause of Death | Transplantation, Homologous | Young Adult | Adolescent | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Aged | Child | Index Medicus | Bone2 | Original Reports | Bone1
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 31, pp. 3497 - 3505
Life Sciences & Biomedicine | Oncology | Science & Technology | Myeloablative Agonists - therapeutic use | Graft vs Host Disease - epidemiology | Busulfan - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Cyclophosphamide - therapeutic use | Incidence | Bayes Theorem | Adult | Female | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning - methods | Index Medicus | ORIGINAL REPORTS | Bone1
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 21, pp. 2662 - 2670
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Markov Chains | Humans | Middle Aged | Decision Support Techniques | Quality of Life | Female | Male | Aged | International Cooperation | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Myelodysplastic Syndromes - surgery | Index Medicus | ORIGINAL REPORTS | Hema5 | Bone1 | Klinisk medicin | Medicin och hälsovetenskap | Kirurgi | Cancer och onkologi
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1663 - 1669
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Age Factors | United States | Humans | Child, Preschool | National Cancer Institute (U.S.) | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Cause of Death | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Time Factors | Female | Retrospective Studies | Child | Severity of Illness Index | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Clinical Trials as Topic | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Disease Progression | Disease-Free Survival | Adolescent | Sex Factors | Survival Analysis | Cohort Studies | Index Medicus | Adolescence | Acute lymphatic leukemia | Cell survival | Risk groups | Toxicity | Clinical trials | Infants | Lymphocytes T | Survival | Races | Lymphocytes B | Ethnic groups | Children | Age | ORIGINAL REPORTS | Bone4 | Bone1
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 28, pp. 3152 - 3161
Life Sciences & Biomedicine | Oncology | Science & Technology | Haplotypes | Hematologic Neoplasms - therapy | Recurrence | Cyclophosphamide - administration & dosage | Age Factors | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents, Alkylating - administration & dosage | HLA Antigens - genetics | Cyclophosphamide - adverse effects | Patient Selection | Graft vs Host Disease - mortality | Time Factors | Female | Retrospective Studies | Chemotherapy, Adjuvant | Graft vs Host Disease - diagnosis | Graft vs Host Disease - etiology | Hematologic Neoplasms - diagnosis | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | HLA Antigens - immunology | Treatment Outcome | Disease Progression | Disease-Free Survival | Bone Marrow Transplantation - mortality | Bone Marrow Transplantation - adverse effects | Aged | Hematologic Neoplasms - genetics | Hematologic Neoplasms - immunology | Tissue Donors | Transplantation Conditioning | Antineoplastic Agents, Alkylating - adverse effects | Index Medicus | Bone2 | ORIGINAL REPORTS | Bone1
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1878 - 1887
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Age Factors | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Neoplasm Recurrence, Local - therapy | Hematopoietic Stem Cell Transplantation | Male | Survival Rate | Treatment Outcome | Remission Induction | Transplantation, Homologous | Neoplasm Recurrence, Local - pathology | Adult | Female | Aged | Transplantation Conditioning | Neoplasm Staging | Leukemia, Myeloid, Acute - therapy | Index Medicus | Original Reports | Bone1
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 22, pp. 2583 - 2590
Life Sciences & Biomedicine | Oncology | Science & Technology | Osteopontin - blood | Prognosis | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Humans | Middle Aged | Chemokine CXCL9 - blood | Hematopoietic Stem Cell Transplantation | Male | Biomarkers - blood | Time Factors | Interleukin-1 Receptor-Like 1 Protein - blood | Adult | Female | Matrix Metalloproteinase 3 - blood | Chronic Disease | Graft vs Host Disease - diagnosis | Postoperative Complications | Index Medicus | ORIGINAL REPORTS | Bone1
Journal Article